Werewolf Therapeutics Inc (HOWL)
4.89
-0.27
(-5.23%)
USD |
NASDAQ |
May 24, 16:00
4.89
0.00 (0.00%)
After-Hours: 19:58
Werewolf Therapeutics Price to Book Value: 1.807 for May 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 23, 2024 | 1.907 |
| May 22, 2024 | 1.807 |
| May 21, 2024 | 1.848 |
| May 20, 2024 | 1.766 |
| May 17, 2024 | 1.744 |
| May 16, 2024 | 1.804 |
| May 15, 2024 | 1.792 |
| May 14, 2024 | 1.822 |
| May 13, 2024 | 1.648 |
| May 10, 2024 | 1.866 |
| May 09, 2024 | 2.058 |
| May 08, 2024 | 2.025 |
| May 07, 2024 | 2.114 |
| May 06, 2024 | 2.21 |
| May 03, 2024 | 2.243 |
| May 02, 2024 | 2.247 |
| May 01, 2024 | 2.225 |
| April 30, 2024 | 2.306 |
| April 29, 2024 | 2.461 |
| April 26, 2024 | 2.488 |
| April 25, 2024 | 2.289 |
| April 24, 2024 | 2.356 |
| April 23, 2024 | 2.374 |
| April 22, 2024 | 2.245 |
| April 19, 2024 | 2.175 |
| Date | Value |
|---|---|
| April 18, 2024 | 2.164 |
| April 17, 2024 | 2.153 |
| April 16, 2024 | 2.068 |
| April 15, 2024 | 2.024 |
| April 12, 2024 | 1.729 |
| April 11, 2024 | 1.869 |
| April 10, 2024 | 1.950 |
| April 09, 2024 | 1.972 |
| April 08, 2024 | 1.983 |
| April 05, 2024 | 2.182 |
| April 04, 2024 | 2.212 |
| April 03, 2024 | 2.219 |
| April 02, 2024 | 2.234 |
| April 01, 2024 | 2.352 |
| March 31, 2024 | |
| March 28, 2024 | 2.487 |
| March 27, 2024 | 2.437 |
| March 26, 2024 | 2.318 |
| March 25, 2024 | 2.306 |
| March 22, 2024 | 2.333 |
| March 21, 2024 | 2.245 |
| March 20, 2024 | 2.345 |
| March 19, 2024 | 2.279 |
| March 18, 2024 | 2.31 |
| March 15, 2024 | 2.356 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3592
Minimum
Dec 07 2022
3.084
Maximum
Jul 02 2021
1.363
Average
1.024
Median
Jul 15 2022
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.695 |
| AIM ImmunoTech Inc | 4.772 |
| IGC Pharma Inc | 3.395 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 3.028 |
Price to Book Value Related Metrics
| PS Ratio | 11.26 |
| Price | 4.89 |
| Earnings Yield | -22.29% |
| Market Cap | 212.50M |